(Q39188767)

9 September 2017

1 reference

title

Varicella-zoster virus infection and immunization in the healthy and the immunocompromised host (English)

1 reference

9 September 2017

0 references

Grose C

1

1 reference

9 September 2017

Giller RH

series ordinal

2

1 reference

9 September 2017

publication date

1 January 1988

1 reference

Critical Reviews in Oncology Hematology

9 September 2017

published in

1 reference

9 September 2017

volume

8

1 reference

9 September 2017

issue

1

1 reference

9 September 2017

page(s)

27-64

1 reference

The complete DNA sequence of varicella-zoster virus

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

The synthesis of glycoproteins in human melanoma cells infected with varicella-zoster virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Immunogenic glycoproteins of laboratory and vaccine strains of Varicella-Zoster virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Immunoprecipitable polypeptides specified by varicella-zoster virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Common expression of varicella-zoster viral glycoprotein antigens in vitro and in chickenpox and zoster vesicles.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Monoclonal antibodies against three major glycoproteins of varicella-zoster virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Structural analysis of the varicella-zoster virus gp98-gp62 complex: posttranslational addition of N-linked and O-linked oligosaccharide moieties

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Synthesis and processing of glycoproteins of Varicella-Zoster virus (VZV) as studied with monoclonal antibodies to VZV antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Processing of virus-specific glycoproteins of varicella zoster virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Three major glycoprotein genes of varicella-zoster virus whose products have neutralization epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Serological reactivity of some monoclonal antibodies to varicella-zoster virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Varicella-zoster viral glycoproteins analyzed with monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Varicella-zoster virus envelope glycoproteins: biochemical characterization and identification in clinical material

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Molecular Dissection of the Humoral Immune Response to Individual Varicella-Zoster Viral Proteins During Chickenpox, Quiescence, Reinfection, and Reactivation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Varicella-zoster virus-specific gpl40: A highly immunogenic and disulfide-linked structural glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Human leukocytes kill varicella-zoster virus-infected fibroblasts in the presence of murine monoclonal antibodies to virus-specific glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Analysis of three late varicella-zoster virus proteins, a 125,000-molecular-weight protein and gp1 and gp3

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Affinity-purified varicella-zoster virus glycoprotein gp1/gp3 stimulates the production of neutralizing antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Glycoprotein gp118 of varicella-zoster virus: purification by serial affinity chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Neutralization epitope of varicella zoster virus on native viral glycoprotein gp118 (VZV glycoprotein gpIII).

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Identification of the products of a varicella-zoster virus glycoprotein gene

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

New common nomenclature for glycoprotein genes of varicella-zoster virus and their glycosylated products.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Varicella-Zoster Virus Infection of Diploid and Chemically Transformed Guinea-pig Embryo Cells: Factors Influencing Virus Replication

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Varicella-zoster virus infection of strain 2 guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Isolation of varicella-zoster virus from blood

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Viremia Caused by Varicella-Zoster Virus: Association with Malignant Progressive Varicella

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Viremic phase in nonimmunocompromised children with varicella

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Isolation of varicella zoster virus from blood.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Viral replication and immunologic responses in children naturally infected with varicella-zoster virus and in varicella vaccine recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Modification of chicken pox in family contacts by administration of gamma globulin

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Reye's syndrome: epidemiologic and viral studies, 1963-1974

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Magnetic resonance imaging of the brain in childhood herpesvirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Multiple congenital defects following maternal varicella; report of a case

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Serologic response to varicella-zoster membrane antigens measured by direct immunofluorescence

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

DNA mapping of paired varicella-zoster virus isolates from patients with shingles

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Endonuclease analysis of viral DNA from varicella and subsequent zoster infections in the same patient

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Varicella-zoster virus RNA in human trigeminal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Varicella-zoster virus DNA in human sensory ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Complement-Enhanced Neutralizing Antibody Response to Varicella-Zoster Virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Zoster in Children with Cancer: Radioimmune Precipitation Profiles of Sera Before and After Illness

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Varicella-zoster virus p32/p36 complex is present in both the viral capsid and the nuclear matrix of the infected cell

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

HLA-D Region Molecules Restrict Proliferative T Cell Responses to Antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Human T-cell cultures from virus-sensitized donors can mediate virus-specific and HLA-restricted cell lysis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Cellular and Humoral Immunity in the Pathogenesis of Recurrent Herpes Viral Infections in Patients with Lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Reduced cellular immunity to varicella zoster virus during treatment for acute lymphoblastic leukemia of childhood: in vitro studies of possible mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Specific lysis of varicella zoster virus-infected B lymphoblasts by human T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Live attenuated varicella vaccine. Efficacy for children with leukemia in remission

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Live attenuated varicella vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Molecular epidemiology of live, attenuated varicella virus vaccine in children with leukemia and in normal adults

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Herpes zoster following varicella vaccine in a child with acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Administration of live varicella vaccine to children wtih leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Zoster immune globulin. A further assessment.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Adenine Arabinoside for Therapy of Herpes Zoster in Immunosuppressed Patients: Preliminary Results of a Collaborative Study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

In vitro susceptibility of varicella-zoster virus to acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Acyclovir therapy of chickenpox in immunosuppressed children--a collaborative study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Varicella pneumonitis: Immunodiagnosis with a monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Treatment of varicella-zoster virus infection in severely immunocompromised patients. A randomized comparison of acyclovir and vidarabine

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

Acyclovir administered perorally in immunocompromised children with varicella-zoster infections

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2888%2980004-0

7 January 2021

10.1016/S1040-8428(88)80004-0

Identifiers

DOI

1 reference

9 September 2017

1 reference